These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents. Emerich DF; Winn SR; Lindner MD Cell Transplant; 1996; 5(5):589-96. PubMed ID: 8889217 [TBL] [Abstract][Full Text] [Related]
5. An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Winn SR; Wahlberg L; Tresco PA; Aebischer P Exp Neurol; 1989 Sep; 105(3):244-50. PubMed ID: 2504616 [TBL] [Abstract][Full Text] [Related]
6. Transplantation of microencapsulated PC12 cells provides long-term improvement of dopaminergic functions. Wang Y; Wang SD; Lin SZ; Chiou AL; Chen LK; Chen JF; Zhou FC Chin J Physiol; 1997 Sep; 40(3):121-9. PubMed ID: 9434887 [TBL] [Abstract][Full Text] [Related]
7. Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in striata of rats with 6-OH-DA induced parkinsonism. McRae A; Dahlström A Neurochem Int; 1994 Jul; 25(1):27-33. PubMed ID: 7950966 [TBL] [Abstract][Full Text] [Related]
8. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
9. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944 [TBL] [Abstract][Full Text] [Related]
11. Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats. Emerich DF; McDermott PE; Krueger PM; Frydel B; Sanberg PR; Winn SR Exp Neurol; 1993 Jul; 122(1):37-47. PubMed ID: 8339788 [TBL] [Abstract][Full Text] [Related]
12. Unilateral implantation of dopamine-loaded biodegradable hydrogel in the striatum attenuates motor abnormalities in the 6-hydroxydopamine model of hemi-parkinsonism. Senthilkumar KS; Saravanan KS; Chandra G; Sindhu KM; Jayakrishnan A; Mohanakumar KP Behav Brain Res; 2007 Nov; 184(1):11-8. PubMed ID: 17765334 [TBL] [Abstract][Full Text] [Related]
13. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats. Rui G; Guangjian Z; Yong W; Jie F; Yanchao C; Xi J; Fen L Behav Brain Res; 2013 Jan; 237():263-9. PubMed ID: 23036843 [TBL] [Abstract][Full Text] [Related]
14. Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats. McRae A; Ling EA; Hjorth S; Dahlström A; Mason D; Tice T Mol Neurobiol; 1994; 9(1-3):191-205. PubMed ID: 7888096 [TBL] [Abstract][Full Text] [Related]
15. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease. Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167 [TBL] [Abstract][Full Text] [Related]
16. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA. Konieczny J; Czarnecka A; Lenda T; Kamińska K; Antkiewicz-Michaluk L Neuroscience; 2017 Jan; 340():308-318. PubMed ID: 27826109 [TBL] [Abstract][Full Text] [Related]